Preclinical CRO
We are thought leaders in pharmacology and imaging.
With expertise in multiple therapeutic areas, our industry knowledgeable scientists provide seamless support for your R&D effort.
PDX models
Our process begins with the right model selection.
With our deep pharmacology and models expertise, your studies are implemented correctly from the beginning.
Molecular Imaging Preclinical Oncology
We stand beside you and your science.
With personalized attention, flexibility and responsiveness, we become an extension of your team.
Preclinical Imaging
We set the standard for industry relevant protocols.
We offer a broad array of efficient, validated pharmacology and imaging protocols to meet your needs.
Knowledge
Process
Partnership
Excellence

Molecular Imaging, Inc. is a specialty CRO combining expertise in small animal in-vivo pharmacology and imaging. Our unique pharmaco-IMAGING platform allows for enhanced decision making in your discovery and development programs. 
For over 10 years, Molecular Imaging has provided pharmacology services and pioneered the application of multi-modality imaging. We have executed over 3,000 studies, 600 of which involved imaging, to more than 150 pharmaceutical and biotechnology clients. 

Latest Headlines

28th May 2015

Attachment of tumor-selective antigens to microparticle carriers stimulates tumor immunity via effects on dendritic cells and interferon pathways.

12th May 2015
Development and progression of a broad range of human cancers is dependent on evasion of the body’s powerful natural immune surveillance mechanisms.

Latest Video

Events

5th Nov 2015
Join us at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Boston, MA
16th Sep 2015
Join us at The Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival
New York, NY

In the News

Spotlight

Have a look at the latest edition of Envision, Molecular Imaging, Inc.'s quarterly newsletter. Click Here

 

 

Home

Preclinical Contract Research Organisation specializing in Multi-Modality Imaging studies across a wide range of Therapeutic Areas that enhance the effectiveness and efficiency of R&D decision making efforts for new drugs, biologics, devices and diagnostics.